106 related articles for article (PubMed ID: 7538355)
1. Parvovirus-based vectors for human gene therapy.
Srivastava A
Blood Cells; 1994; 20(2-3):531-6; discussion 536-8. PubMed ID: 7538355
[TBL] [Abstract][Full Text] [Related]
2. Parvovirus vectors for human gene therapy.
Srivastava A
Curr Opin Mol Ther; 2001 Oct; 3(5):491-6. PubMed ID: 11699894
[TBL] [Abstract][Full Text] [Related]
3. Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene.
Shelling AN; Smith MG
Gene Ther; 1994 May; 1(3):165-9. PubMed ID: 7584077
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells.
Kurpad C; Mukherjee P; Wang XS; Ponnazhagan S; Li L; Yoder MC; Srivastava A
J Hematother Stem Cell Res; 1999 Dec; 8(6):585-92. PubMed ID: 10645765
[TBL] [Abstract][Full Text] [Related]
6. In vitro packaging of an infectious recombinant adeno-associated virus 2.
Ding L; Lu S; Munshi NC
Gene Ther; 1997 Nov; 4(11):1167-72. PubMed ID: 9425439
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.
Hermonat PL; Santin AD; De Greve J; De Rijcke M; Bishop BM; Han L; Mane M; Kokorina N
J Hum Virol; 1999; 2(6):359-68. PubMed ID: 10774553
[TBL] [Abstract][Full Text] [Related]
8. Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells.
Sellner L; Stiefelhagen M; Kleinschmidt JA; Laufs S; Wenz F; Fruehauf S; Zeller WJ; Veldwijk MR
Exp Hematol; 2008 Aug; 36(8):957-64. PubMed ID: 18495326
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood.
Zhou SZ; Cooper S; Kang LY; Ruggieri L; Heimfeld S; Srivastava A; Broxmeyer HE
J Exp Med; 1994 Jun; 179(6):1867-75. PubMed ID: 7515101
[TBL] [Abstract][Full Text] [Related]
10. Stable integration of retrovirally transduced genes into human umbilical cord blood high-proliferative potential colony-forming cells (HPP-CFC) as assessed after multiple HPP-CFC colony replatings in vitro.
Lu L; Xiao M; Clapp DW; Li ZH; Broxmeyer HE
Blood Cells; 1994; 20(2-3):525-30. PubMed ID: 7749119
[TBL] [Abstract][Full Text] [Related]
11. Adeno-associated virus 2-mediated gene transfer in murine hematopoietic progenitor cells.
Zhou SZ; Broxmeyer HE; Cooper S; Harrington MA; Srivastava A
Exp Hematol; 1993 Jul; 21(7):928-33. PubMed ID: 8391471
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of a recombinant adeno-associated virus 2 vector in human CD34+ cells and breast cancer cells.
Veldwijk MR; Fruehauf S; Schiedlmeier B; Kleinschmidt JA; Zeller WJ
Cancer Gene Ther; 2000 Apr; 7(4):597-604. PubMed ID: 10811478
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer into hematopoietic progenitor and stem cells: progress and problems.
Dunbar CE; Emmons RV
Stem Cells; 1994 Nov; 12(6):563-76. PubMed ID: 7881358
[TBL] [Abstract][Full Text] [Related]
14. Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV.
Nathwani AC; Hanawa H; Vandergriff J; Kelly P; Vanin EF; Nienhuis AW
Gene Ther; 2000 Feb; 7(3):183-95. PubMed ID: 10694794
[TBL] [Abstract][Full Text] [Related]
15. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo.
Zhong L; Chen L; Li Y; Qing K; Weigel-Kelley KA; Chan RJ; Yoder MC; Srivastava A
Mol Ther; 2004 Nov; 10(5):950-7. PubMed ID: 15509512
[TBL] [Abstract][Full Text] [Related]
16. Detection of adeno-associated virus type 2 in sorted human bone marrow progenitor cells.
Anderson RJ; Galatowicz G; Macdonald ID; Lowdell MW; Corbett TJ; Prentice HG
Exp Hematol; 1997 Mar; 25(3):256-62. PubMed ID: 9091303
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in adeno-associated virus vector technology.
Büning H; Perabo L; Coutelle O; Quadt-Humme S; Hallek M
J Gene Med; 2008 Jul; 10(7):717-33. PubMed ID: 18452237
[TBL] [Abstract][Full Text] [Related]
18. Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection.
Ponnazhagan S; Wang XS; Woody MJ; Luo F; Kang LY; Nallari ML; Munshi NC; Zhou SZ; Srivastava A
J Gen Virol; 1996 Jun; 77 ( Pt 6)():1111-22. PubMed ID: 8683195
[TBL] [Abstract][Full Text] [Related]
19. The use of recombinant adeno-associated virus for skeletal gene therapy.
Dai J; Rabie AB
Orthod Craniofac Res; 2007 Feb; 10(1):1-14. PubMed ID: 17284242
[TBL] [Abstract][Full Text] [Related]
20. Transient gene expression by nonintegrating lentiviral vectors.
Nightingale SJ; Hollis RP; Pepper KA; Petersen D; Yu XJ; Yang C; Bahner I; Kohn DB
Mol Ther; 2006 Jun; 13(6):1121-32. PubMed ID: 16556511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
